Krier, J. et al. PDE4D and PDE3B orchestrate distinct cAMP microdomains in 3T3-L1 adipocytes. Br. J. Pharmacol., DOI: 10.1111/bph.70216 (2025)
Lynderup, E.M.* et al. Methanobactin rapidly facilitates biliary copper excretion in a Wilson disease rat model visualised by 64Cu PET/MRI. Br. J. Pharmacol., DOI: 10.1111/bph.70099 (2025)
Kogut-Günthel, M.M.* et al. The path to the G protein-coupled receptor structural landscape: Major milestones and future directions. Br. J. Pharmacol., DOI: 10.1111/bph.17314 (2024)
Benkner, A.* et al. Riociguat attenuates left ventricular proteome and microRNA profile changes after experimental aortic stenosis in mice. Br. J. Pharmacol. 179, 4575-4592 (2022)
Costa, R. et al. A drug screen with approved compounds identifies amlexanox as a novel Wnt/β-catenin activator inducing lung epithelial organoid formation. Br. J. Pharmacol. 178, 4026-4041 (2021)
Sander, P.* et al. Approved drugs ezetimibe and disulfiram enhance mitochondrial Ca2+ uptake and suppress cardiac arrhythmogenesis. Br. J. Pharmacol., DOI: 10.1111/bph.15630 (2021)
Rüdebusch, J.* et al. Stimulation of soluble guanylyl cyclase (sGC) by riociguat attenuates heart failure and pathological cardiac remodelling. Br. J. Pharmacol., DOI: 10.1111/bph.15333 (2020)
Ehrhardt, H. et al. Enhanced anti-tumour effects of vinca alkaloids given separately from cytostatic therapies. Br. J. Pharmacol. 168, 1558-1569 (2013)